Literature DB >> 9700200

Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.

B Doray1, R Salomon, J Amiel, A Pelet, R Touraine, M Billaud, T Attié, B Bachy, A Munnich, S Lyonnet.   

Abstract

Hirschsprung disease (HSCR) is a frequent neurocristopathy characterized by the absence of submucosal and myenteric plexuses in a variable length of the gastrointestinal tract. Pedigrees and segregation analyses suggested the involvement of one or several dominant genes with low penetrance in HSCR. Considering that RET and glial cell line-derived neurotrophic factor (GDNF) mutations have been reported in the disease, we regarded the other RET ligand, neurturin (NTN), as an attractive candidate gene, especially as it shares large homologies with GDNF. Here, we report on the finding of a heterozygous missense NTN mutation in a large non-consanguineous family including four children affected with a severe aganglionosis phenotype extending up to the small intestine. Interestingly, it appears that the NTN mutation reported here is not sufficient to cause HSCR, and this multiplex family also segregates a RET mutation. This cascade of independent and additive genetic events fits well with the multigenic pattern of inheritance expected in HSCR, and further support the role of RET ligands in development of the enteric nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700200     DOI: 10.1093/hmg/7.9.1449

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

Review 1.  Developmental disorders of the enteric nervous system.

Authors:  R P Kapur
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

3.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

Review 4.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

5.  Association study of PHOX2B as a candidate gene for Hirschsprung's disease.

Authors:  M Garcia-Barceló; M H Sham; V C H Lui; B L S Chen; J Ott; P K H Tam
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

Review 6.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

7.  The microenvironment in the Hirschsprung's disease gut supports myenteric plexus growth.

Authors:  Cornelia Irene Hagl; Ulrich Rauch; Markus Klotz; Sabine Heumüller; David Grundmann; Sabrina Ehnert; Ulrike Subotic; Stefan Holland-Cunz; Karl-Herbert Schäfer
Journal:  Int J Colorectal Dis       Date:  2012-06       Impact factor: 2.571

Review 8.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

9.  Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb.

Authors:  Andrew S McCallion; Erine Stames; Ronald A Conlon; Aravinda Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

Review 10.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.